Hosted on MSN33m
Neoadjuvant Chemoradiation Plus Immunotherapy Boosts Responses in Esophageal Cancer
The phase III ESCORT-NEO trial evaluated camrelizumab in combination with chemotherapy versus chemotherapy alone in the ...